These findings suggest that LAPTM4B and SLC7A11 are coordinately involved in regulating ferroptosis in NSCLC patients, which further influences the progression of NSCLC and the survival probability of patients. The gene discussed is SLC7A11; the disease is non-small cell lung carcinoma.